Wu, Lucia Ruojia http://orcid.org/0000-0001-5051-9685
Dai, Peng http://orcid.org/0000-0002-4581-3473
Wang, Michael Xiangjiang http://orcid.org/0000-0001-7009-6958
Chen, Sherry Xi
Cohen, Evan N. http://orcid.org/0000-0003-4192-9644
Jayachandran, Gitanjali
Zhang, Jinny Xuemeng
Serrano, Angela V.
Xie, Nina Guanyi
Ueno, Naoto T. http://orcid.org/0000-0002-0166-7275
Reuben, James M.
Barcenas, Carlos H.
Zhang, David Yu
Funding for this research was provided by:
Division of Cancer Prevention, National Cancer Institute (U01CA233364, R01CA203964)
Cancer Prevention and Research Institute of Texas (RP180147)
Article History
Received: 20 September 2021
Accepted: 18 March 2022
First Online: 4 April 2022
Competing interests
: A US provisional patent application (No. 62/788,375) and an international patent application (No. PCT/US2020/012089) covering the use of QASeq technology have been filed in which the Rice University is the applicant, and D.Y.Z., L.R.W., P.D. are the inventors. P.D., L.R.W., S.X.C., and M.X.W. declares a competing interest in the form of consulting for NuProbe USA. D.Y.Z. is a co-founder and holds significant equity in NuProbe Global, Torus Biosystems, and Pana Bio. The remaining authors declare no competing interests.